Title: Endotracheal Intubation with Cisatracurium Vs Rocuronium: A Comparative Study

Authors: Dr Uday Kumar. G, Dr Kiran Kumar. Suggala, Dr B.Kishan Rao

 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.193

Abstract

The present study cisatracurium vs rocuronium for endotracheal intubation in adult patients was undertaken to compare  the onset of action, intubating conditions, recovery time from neuromuscular blockade, hemodynamic effects of cisatracrium 0.15 mg/kg and rocuronium 0.6mg/kg in 100 adult patients between 20-60 years of age, with ASA physical status I and II of either sex posted for elective surgical procedures after induction with intravenous propofol 2mg/kg and followed by fentanyl 2mcg/kg iv injection. In our study we found that onset of action was quicker and intubating conditions are better and faster with rocuronium (92.02±12.33) compared to cisatracrium(188.45±33.42). There was no statistically significant changes in hemodynamic parameters with both drugs. Intubating conditions were assessed by modified grading given by Cooper et al. It was excellent in 72%, good in 22% and fair in 2% of patients in cisatracrium group, and it was excellent in 78%, good in 14% and fair in 8% of patients in rocuronium group. In all patient the recovery time at TOF>0.9 was between 30–110min. Mean recovery time was 59.33±15.56 and 53±10.23 min in cisatracrium and rocuronium groups respectively. It can be concluded that rocuronium has a rapid onset, time to excellent intubating conditions was significantly faster but both drugs were producing excellent to good intubating conditions with minimal hemodynamic changes and no adverse effects in adult patients of age 20-60 years posted for elective surgery.

Keywords: cisatracurium , rocuronium , endotracheal intubation, on set time, recovery time

References

  1. Larijani GE, Gratz I, Silverberg M, Jacobi Clinical pharmacology of the neuromuscular blocking agents. DICP. 1991;25:54–64. [PubMed]
  2. Movafegh A, Amini S, Sharifnia H, Torkamandi H, Hayatshahi A, Javadi M. Cost analysis and safety comparison of Cisatracurium and Atracurium in patients undergoing  general  Eur Rev   Med   Pharmacol   Sci. 2013;17:447–450.
  3. Belmont MR, Lien CA, Quessy S, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxidelopioidlbarbiturate anesthesia. Anesthesiology 1995;82:1139-1145.
  4. Lepage JY, Malinovsky JM, Malinge M, et al. Pharmacodynamic dose-response and safety study of cisatracurium (51W89) inadult surgical patients during N,O-O,-opioid anesthesia.Anesth Analg 1996;83:823-9.
  5. Melling holf,redbruch L, Diefenbach C, Buzello W. A comparison comparisonof cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion. Anesth Analg 1996;83: 1072-5.
  6. Cooper R, Mirakhur RK, Clarke RSJ, Boules Z. Comparison of intubating conditions after administration of ORG 9426 (Rocuronium) and suxamethonium. British J Anaesth 1992; 69:269-73.
  7. Doenicke AW, Czeslick E, Moss J, et al. Onset time, endotracheal intuba- tion, and plasma histamine after cisatracurium and vecuronium administration. Anesth &Analg 1998; 87:
  8. Kim KS, Chung CW, Chin WJ. Cisatracurium neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans. BJA 1999; 83:483.
  9. Ko Yk, Kim YH,Park SI, Chung WS,Noh C, Lee JU. Korean J Anesthesiol 2015 Apr;68(2):136-40. doi: 10.4097/kjae.2015.68.2.136. Epub 2015 Mar30.
  10. Paśko-Majewska M, Owczuk R, Wujtewicz M. Comparison of atracurium, cisatracurium and vecuronium during anaesthesia for laparoscopic Anestezjol Intens Ter. 2011;43(1):9-13.
  11. Adamus M, Hrabalek L, Wanek T, Gabrhelik T, Zapletalova J. Influence of age and gender on the pharmacodynamic parameters of rocuronium during total intravenous anesthesia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(4):347–353. doi: 10.5507/bp.2011.050. [PubMed]
  12. Melloni C, Devivo P, Launo C, Mastronardi P, Novelli GP, Romano E. Cisatracurium versus vecuronium: a comparative, double blind, randomized, multicenter study in adult patients under propofol/fentanyl/N2O anesthesia. Minerva Anestesiol. 2006;72:299–308.
  13. Parasa M, Vemuri NN, Shaik MS. Comparison of equipotent doses of rocuronium and vecuronium. Anesth Essays Res. 2015;9(1):88-91.
  14. Misra MN, Agarwal M, Pandey RP, Gupta A. A comparative study of rocuronium, vecuronium and succinylcholine for rapid sequence induction of anesthesia. Indian J Anaesth. 2005;49:469–73.
  15. Smith j and Saad R S G. Comparison of intubating conditions after rocuronium or vecuronium when the timing of intubation is judged by clinical criteria. British Journal of Anaesthesia 1998; 80: 235–237.
  16. Lee H, Jeong S, Choi C, Jeong H, Lee S, Jeong S. Anesthesiologist’s satisfaction using between cisatracurium and rocuronium for the intubation in the anesthesia induced by remifentanil and propofol. Korean Journal of Anesthesiology. 2013;64(1):34-39.
  17. Sagir O, Yucesoy Noyan F, Koroglu A, Cicek M, Ilksen Toprak Comparison between the Effects of Rocuronium, Vecuronium, and Cisatracurium Using  Train-of-Four  and  Clinical  Tests  in  Elderly Patients. Anesthesiology and Pain Medicine. 2013;2(4):142-148
  18. Shaik mira shareef, G sudharani. Comparative study of Succinylcholine, Rocuronium and Vecuronium for intubation and hemodynamic changes during general anaesthesia. IOSR-JDMS 2016; 15(10): pp14-19.
  19. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000.Anesthesiology 2003; 99:536–45.
  20. Naguib M, Seraj M, Abdulrazik E. Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, enflurane, isoflurane, and halothane anesthesia in surgical patients. AnesthAnalg 1992;75:193-7.

Corresponding Author

Dr. Kiran Kumar. Suggala

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile no: 8919426610